Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

G2 Energy Corp C.GTOO

Alternate Symbol(s):  GTGEF

G2 Energy Corp. is a Canada-based junior oil and gas producer. The Company is focused on acquiring and developing opportunities in the oil and gas sector. The Company seeks to acquire a portfolio of risk-managed production and development opportunities onshore, in the United States of America. The Company's asset portfolio includes the Masten Unit, which is an approximately 2,600 acres producing unit located within the prolific billion-barrel Levelland Field in Cochran County, Texas. The Company has approximately four wells operating.


CSE:GTOO - Post by User

Post by Abitoon Jul 15, 2020 5:52pm
251 Views
Post# 31273052

news

news

 

Green 2's Arsenal enters partnership with Korean firm

 

2020-07-06 18:04 ET - News Release

 

Mr. Slawek Smulewicz reports

GREEN 2 BLUE SUBSIDIARY ENTERS MEDICAL TECHNOLOGY FIELD

Green 2 Blue Energy Corp.'s wholly owned subsidiary, Arsenal Health Sciences Corp., has entered into a 90-day interim partnership agreement with a private firm based in Korea that includes an option to execute a definitive agreement after 90 days, upon mutual agreement of the parties. The interim partnership agreement gives Arsenal the right to act as an authorized vendor for a number of Korean medical and bioscience companies that conduct research and manufacture products related to immunological diagnostics and blood monitoring. The products, which bear various approvals from the Conformite Europeene (CE), the U.S. Food and Drug Administration (FDA), and/or Health Canada, aid in the diagnosis and monitoring of a variety of medical conditions and pathogens, including SARS-CoV-2 (the COVID-19 virus). This is the next step in Arsenal's continuing exploration of commercial opportunities in the medical technology sector. Arsenal is devising a strategy to distribute testing products, and collect and commercialize anonymized diagnostic data on a large scale. Arsenal is also evaluating the possible benefits of incorporating blockchain technology into its data collection and storage processes.

"Today, Arsenal has entered into an agreement that represents continued forward momentum as Arsenal explores medical technology opportunities around the world," commented Slawek Smulewicz, chief executive officer of Green 2 Blue. "We are confident that the experience and expertise offered by Arsenal's Korean partners will aid Arsenal in meeting its diagnostics technology and data platform objectives," continued Mr. Smulewicz.

Arsenal chief executive officer John Costigan commented, "Arsenal is positioning itself to be a contender in the diagnostics and medical data spheres, and we believe the relationships we have established in Korea will provide a pathway for us to meet our goals."

About Green 2 Blue Energy Corp.

Green 2 Blue is focused on developing opportunities in clean tech and emerging technologies

<< Previous
Bullboard Posts
Next >>